Starboard to vote against Bristol-Myers-Celgene $74 billion deal
February 28, 2019
Sunrise hits snag after announcing $6.3 billion deal for Liberty Global’s Swiss assets
February 28, 2019

Celgene slumps as Bristol-Myers shareholder resists merger

Shares of Celgene Corp dived 8 percent on Thursday after a major shareholder in Bristol-Myers Squibb Co came out against a $74 billion merger that would be the pharmaceutical world’s biggest ever takeover.

Powered by WPeMatico